Nn6535-4725
Research payments
$10,818,859
Through program year 2025, $10,818,859 in research payments was reported against Nn6535-4725, across 3,727 payments.
- Paid by (largest first)
- Novo Nordisk AS; Novo Nordisk Inc
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
5 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | Research | $1,745,422 | 529 |
| 2024 | Research | $1,922,171 | 1,118 |
| 2023 | Research | $4,572,781 | 1,129 |
| 2022 | Research | $2,230,913 | 708 |
| 2021 | Research | $347,572 | 243 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Allison Perrin Phoenix, AZ Named on 138 payments
- Paul Schulz Houston, TX Named on 78 payments
- Victor Faradji Miami, FL Named on 72 payments
- Babak Tousi Cleveland, OH Named on 67 payments
- Shahin Shirzadi Houston, TX Named on 61 payments
- Bart Sloan Norwalk, CT Named on 55 payments
- David Podwall Lake Success, NY Named on 54 payments
- Malisa Agard Orlando, FL Named on 52 payments
- Sarah Land Tulsa, OK Named on 49 payments
- Jose Cardona Miami, FL Named on 49 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.